Unterehmen auf Watchlist setzen
Renovaro Biosciences
ISIN: US29350E1047
WKN: A2PBYQ
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Renovaro Biosciences · ISIN: US29350E1047 · PR Newswire (ID: 20230929NY25503)
29 September 2023 07:23PM

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APRN, RENB, TALS, WMC


NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Blue Apron Holdings, Inc. (NASDAQ: APRN)'s sale to Wonder Group for $13.00 in cash per share of Class A common stock. If you are a Blue Apron shareholder, click here to learn more about your rights and options.

Renovaro Biosciences Inc. (NASDAQ: RENB)'s merger with GEDi Cube Intl Ltd. Under the terms of the proposed transaction, all of GEDi Cube's outstanding equity interests will be exchanged for shares of Renovaro common stock. If you are a Renovaro shareholder, click here to learn more about your rights and options.

Talaris Therapeutics, Inc. (NASDAQ: TALS)'s merger with Tourmaline Bio, Inc. Talaris shareholders immediately prior to the proposed transaction are expected to own approximately 21.3% of the combined company. If you are a Talaris shareholder, click here to learn more about your rights and options.

Western Asset Mortgage Capital Corporation (NYSE: WMC)'s sale to AG Mortgage Investment Trust, Inc. for stock and cash. Upon the closing of the merger, Western Asset shareholders are expected to own approximately 31% of the combined company's stock. If you are a Western Asset shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-aprn-renb-tals-wmc-301943110.html

SOURCE Halper Sadeh LLP

Visuelle Wertentwicklung / Kursverlauf · Renovaro Biosciences
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942